Day 2 :
Keynote Forum
David H Van Thiel
Advanced Liver and Gastrointestinal Disease Center, USA
Keynote: Subsequent clinical exocrine pancreatic insufficiency, a disease requiring recognition and therapy
Time : 09:00-09:40
Biography:
Abstract:
Gastroesophageal reflux is a condition that occurs when gastric (GERD) or gastroduodenal (EDRD) content refluxes into the esophagus. Depending upon the degree to which duodenal secretions contaminate the gastric refluxate the refluxed material can be acidic (pH less than 4 for gastric reflux), mildly acidic (pH ranging between 4 but < 7, mildly ascitic), or alkaline (pH greater or equal 7). The patient's symptoms are a reflection of the degree of tissue inflammation plus or minus tissue injury (erosions or ulceration) produced rather than the specific nature of the refluxed material. Continued uncontroled/chronic reflux leads to the complications of GERD/GDRD consisting of inflammation that can progress to erosions, ulcerations, or scarring (stricture), mucosal metaplasia (Barrett's esophagus) or adenocarcinoma.
GERD is a common disorder with a world prevalence that somewhat between 10 and 30% of the population being less commonly seen in Asia as compared to Europe or the Americas. Clinical GERD is estimated to be seen in 7% of the population is manifested as ‘ heartburn" and accounts for 4% of the visits to primary care physicians and is the most common reason for referral to gastroenterologist.
Complicated GERD is manifested by “alarm signals” consisting of weight loss, odynophagia, dysphagia, regurgitation, anemia and a variety of extra- esophageal symptoms ascribed to GERD consisting of hoarseness, laryngitis, bronchitis, dental enamel erosion, otitis media, sinusitis, pseudo- angina, sleep dysfunction, asthma, pneumonitis, and pulmonary fibrosis. In addition, as a consequence of the almost universal use of proton pump inhibitors for the treatment of GERD an increase in cases of community-acquired and hospital-acquired pneumonia have been reported in the elderly as a direct consequence of the reduction in the acid secretion by the stomach and the resultant increase in viable gastric microbial concentrations.
Risk factors for GERD are common in the population and consist of the existence of a hiatal hernia, obesity, type 2 diabetes mellitus, hypertension, hyperlipidemia, advanced age, chronic hiccups, asthma, and less often sinusitis, chronic recurrent otitis media and dental erosions. Because heartburn can be treated very effectively with proton pump inhibitors there is no need for endoscopy or other invasive diagnostic procedures to establish a diagnosis in cases of simple heartburn, GERD, or GERD. The use of endoscopy, pH monitoring, with without impedance determination, and esophageal manometry are reserved for those individuals manifesting "alarm symptoms", those who have failed treatment with a proton pump inhibitor and those being considered for reflux surgery. Endoscopy is used to grade the severity of reflux inflammation and the identification of erosions or ulcerative disease and assess the patient for the more severe or advanced complications consisting of stricturing, Barrett's esophagus and/or adenocarcinoma. Ambulatory pH monitoring is used to document reflux and define its character (acid, mildly acid, or alkaline), its frequency, and duration as well as its relationship with symptoms as reported by the patient. Manometry enables a quantitative assessment of esophageal motility and measurement of the frequency of transient esophageal relaxations, and the duration of the reflux exposure as well as the ability to rule out the presence of achalasia, a contraindication to reflux surgery.
Reproducible therapies of GERD consist of the administration of proton pump inhibitor taken one to 2 hours before the first meal of the day for 12 weeks. Failure to respond to find a symptomatic relief is managed by a doubling of the morning proton pump inhibitor dose with or without the addition of an H2 receptor antagonist at that time which is utilized particularly for those with nocturnal reflux symptoms or sleep apnea.
Prokinetic agents are used exclusively when alkaline reflux is present to prevent alkaline reflux by increasing esophageal contractions (esophageal clearance), to increase lower esophageal resting pressure to prevent reflux , and enhancement of gastric and duodenal motility there by reducing the volume of gastric/duodenal content available for reflux. The use of these agents is limited by the development of tolerance within a short period of time, their short duration of action, and their adverse effects consisting of tremor, fatigue and cardiac arrhythmias.
A large number of abnormal anatomic variations at the gastroesophageal junction and physiologic and neuroendocrine reflexes occur as high frequency in cases of GERD and our thought to contribute to the pathophysiology of the disorder. Disease consist in part consist of lower esophageal sphincter incompetence, reduced resting lower esophageal pressure, the presence of a hiatal hernia, reduced esophageal clearance, increased frequency of transient esophageal relaxations, esophageal, gastric and/or duodenal motility disorders. With the exception of surgical repair of anatomic variants, the identification of these abnormalities has not contributed substantially to the treatment of GERD/GDRD. This is particularly true of the research directed at the identification of neuro- and endocrine mechanisms that could contribute to esophageal dysfunction and reflux.
For those who fail extended proton pump therapy or develop complications including an esophageal stricture, Barrett's esophagus, esophageal cancer, chronic intractable reflux symptoms often manifested as chronic hiccups, or morbid obesity, surgery is the treatment of choice and consists of any variation of the Nyssen procedure done laparoscopically or any of the variations bariatric surgery. These surgical procedures produce long-term benefit but often with minor relapses that necessitate the use of an additional acid inhibitory agent for a PPI or H2 receptor antagonists and occasionally a prokinetic agent as well.
Recently, a large variety of endoscopic procedures consisting suturing the lower esophageal sphincter, Silastic implants and endoscopic fundoplication have been developed with for use in the treatment of GERD, but these agents are agents are still investigational and have not yet obtained FDA approved
- Hepatobiliary | IBD/ Endoscopy
Location: Olimpica 2
Chair
David H Van Thiel
Advanced Liver and Gastrointestinal Disease Center, USA
Co-Chair
Errawan R Wiradisuria
Indonesian Society of Endo-Laparoscopic Surgeons (ISES), Indonesia
Session Introduction
Luis A hernandez Higareda
Hospital of Traumatology "Lomas Verdes". (HTOLV). IMSS, Mexcico
Title: Current criteria for colostomy in trauma
Time : 14:00-14:20
Biography:
Luis Hernandez-Higareda completed his Pre-grade in Biological Sciences at cyto-histopathology clinic and medicine at University of Guadalajara. He did his Post-graduation in Intensive Care, Clinical Epidemiology, and Master of Surgery at National Medical Center West, Mexican Social Security Institute (IMSS)-University of Guadalajara. He has undergone training in Gastrointestinal and Airway Endoscopy and Thoracoscopy at National Medical Center La Raza, IMSS, National Autonomous University of Mexico (UNAM). He completed courses in General Surgery and Endoscopic Ultrasound from XXI Century National Medical Center IMSS. He was trained in Surgery of Trauma at Trauma Hospital Lomas Verdes IMSS.
Abstract:
Biography:
Gerard E Mullin is a board-certified Internist, Gastroenterologist and Nutritionist. He is an Associate Professor of Medicine and Director of Integrative GI Nutrition Services at Johns Hopkins Hospital. He is regarded as an authority in integrative gastroenterology. He teaches medical professionals at international conferences on “The role of nutrition and lifestyle and the gut microbiome in digestive health and weight control”. He is the author of several professional desk references and trade books including his latest book The Gut Balance Revolution: Boost Your Metabolism, Restore Your Inner Ecology, and Lose the Weight for Good!
Abstract:
The pathophysiology of obesity is still unknown but there is mounting evidence that the gut microbiome, intestinal permeability and systemic inflammation may play an important role in disease pathogenesis and possibly treatment. Alterations in diet have been shown to shift the gut microbiome's effects on metabolism and regulation of body weight. This session will provide a focused overview of the scientific literature regarding the potential role of gut microbiome as a therapeutic target of weight management. The lecture will first review the pathophysiology of obesity from a functional medicine perspective and discuss how a functional medicine evidence-based approach can achieve optimal weight management by three steps: Remove; restore and renew. Learning objectives are to: Discuss the influence of the gut microbiome on energy metabolism; understand how disruption of the gut microbiome can lead to obesity and; know how prebiotic and probiotic foods and supplements may influence weight by favorably altering the gut microbiome.
Yoriaki Komeda
Kindai University, Japan
Title: Therapeutic strategies for four subtypes of laterally spreading tumors (LSTs) of the colorectum
Time : 16:20-16:40
Biography:
Yoriaki Komeda studied Medicine at Kitasato University in 1974. In 2001, he started his formal training in Internal Medicine at Nara Medical University. He completed his training in Gastroenterology and became a Specialist in Japanese Society of Gastroenterology in 2011. He was a Clinical Research Fellow at St. Mark’s Hospital in London, UK in 2011 and Erasmus Medical Center in Rotterdam, Netherlands in 2012. He became a staff member in Gastroenterology department at Kindai University in 2014. His special interests are “Advanced interventional endoscopic techniques such as endoscopic treatment of early gastro-intestinal cancers”. He has published more than 15 papers in reputed journals.
Abstract:
Yoriaki Komeda
Kindai University, Japan
Title: Therapeutic strategies for four subtypes of laterally spreading tumors (LSTs) of the colorectum
Biography:
Yoriaki Komeda studied Medicine at Kitasato University in 1974. In 2001, he started his formal training in Internal Medicine at Nara Medical University. He completed his training in Gastroenterology and became a Specialist in Japanese Society of Gastroenterology in 2011. He was a Clinical Research Fellow at St. Mark’s Hospital in London, UK in 2011 and Erasmus Medical Center in Rotterdam, Netherlands in 2012. He became a staff member in Gastroenterology department at Kindai University in 2014. His special interests are “Advanced interventional endoscopic techniques such as endoscopic treatment of early gastro-intestinal cancers”. He has published more than 15 papers in reputed journals.
Abstract:
Radosvet Gornev
University Hospital Lozenentz Sofia, Bulgaria
Title: Colorectal cancer: Current issues in Bulgaria
Time : 16:00-16:20
Biography:
Radosvet Gornev is a Head of General Surgery department at University Hospital Lozenentz Sofia, Bulgaria. He is an Assistant Professor of Surgery at Sofia University “St. Kliment Ohridski”. He works at UH Lozenetz Sofia, Bulgaria since 2008. He has experience in “General and colorectal surgery, research, evaluation, teaching and administration both in hospital and education institutions”. From 2008, he is a part of liver transplant program at UH Lozenez, Bulgaria. He has passed a lot of practical modules in different European countries and did research fellowship at Clivland Clinic, USA during 2003.
Abstract:
Chung-Hung Yeh
St. Martin De Porres Hospital, Taiwan
Title: Update of stapled anorectal surgery
Time : 15:40-16:00
Biography:
Chung-Hung Yeh has completed his Medical Degree at Taipei Medical University. After, he completed General Surgical training in 1995; he completed his Colorectal Surgical training at Chang-Gang Memorial Hospital (CGMH), and became the Director of Department of Colorectal Surgery at Chai-Yi CGMH from 2001 to 2009. He has published more than 25 papers in reputed journals and was a Senior Lecturer at Chang-Gang Medical School. He serves as Deputy Director of Surgical department at St. Martin De Porres Hospital since 2013.
Abstract:
M Iqbal Rivai
Andalas University, Indonesia
Title: Laparoscopic Colorectal Surgery
Time : 15:20-15:40
Biography:
M Iqbal Rivai is currently working in General Hospital of Dr. M. Djamil Padang, Indonesia. He has worked for more than 10 years in the related field and gained a plethora of knowledge in related field. His international experience includes various programs, contributions to reputed journals and participation in different international conferences in diverse fields of study.
Abstract:
Reno Rudiman
Padjadjaran University, Indonesia
Title: Recent Advances in Surgical Endoscopy
Time : 14:40-15:00
Biography:
Abstract:
Gastrointestinal endoscopy is a medical instrument for examining the interior canal of digestive tract. The use of the tool has been reported as early as 1822 by William Beaumont. Modern endoscopy as what we now daily use, has been invented in 1983. Various digestive diseases that previously must be diagnosed and treated by invasive method can now take the advantage of flexible endoscopy with ease of procedure and excellent diagnostic accuracy, and can even achieve therapeutic results without open surgery. This presentation will show a brief history of GI endoscopy, listing indications of endoscopy, and more importantly will show recent advances in the field of surgical endoscopy. Clinical results, success rate as well as its complications will be discussed.
Alexander Natroshvili
I.M. Sechenov First Moscow State Medical University, Russia
Title: First results of modified diagnostic scale use for patients with possible appendicitics
Time : 14:20-14:40
Biography:
Abstract:
Wai-Kay Seto
The University of Hong Kong, Hong Kong
Title: Non-invasive assessment of liver fibrosis and steatosis
Time : 09:40-10:00
Biography:
Wai-Kay Seto completed his Medical degree in 2003 and Doctor of Medicine in 2012. He is currently a Clinical Associate Professor in Department of Medicine at University of Hong Kong. He is also a fellow in Gastroenterology and Hepatology and Consultant of Medicine at University of Hong Kong-Shenzhen Hospital, Shenzhen, China. He has published more than 100 peer-reviewed articles in high-impact peer-reviewed journals, including first-authored articles in Journal of Clinical Oncology, Gut, Hepatology, Journal of Hepatology and American Journal of Gastroenterology. He has been awarded numerous research awards by Hong Kong College of Physicians.
Abstract:
Liver biopsy has long been an imperfect gold standard for the assessment of liver fibrosis. While liver biopsy is still widely considered in the disease assessment of viral hepatitis and non-alcoholic steatohepatitis, its invasive nature means it is seldom used to assess treatment response in stable and asymptomatic patients. Non-invasive methods of liver fibrosis are gradually emerging. Serum-based markers e.g. enhanced liver fibrosis score have been shown to correlate strongly with actual histology for multiple chronic liver diseases. Another method of assessing is liver stiffness measurements via transient elastography, a non-invasive ultrasound-based method that is easily performed with high reproducibility. Liver stiffness measurements have been well-validated in chronic hepatitis B, chronic hepatitis C and non-alcoholic fatty liver disease. In addition, liver stiffness measurements have been shown to have prognostic value on the development of cirrhotic complications, hepatocellular carcinoma and all-cause mortality. Evidence on the role of liver stiffness measurement in the clinical monitoring of treatment response is also emerging. Transient elastography also allows the measurement of controlled attenuation parameter, a quantitative marker of steatosis. Transient elastography is now recommended by multiple international guidelines as an assessment tool for chronic liver diseases. There are also other methods of liver fibrosis assessment, e.g. magnetic resonance imaging-based methods that are currently in development.
Kenro Kawada
Tokyo Medical and Dental University, Japan
Title: Observation of the pharynx to the cervical esophagus using transnasal endoscopy with image enhanced endoscopy
Time : 12:40-13:00
Biography:
Abstract:
Alexander Surya Agung
Bhayangkara Police Hospital, Indonesia
Title: Laparoscopic Inguinal Hernia Repair TAPP under Regional Aneshesia: Clinical Experience
Time : 12:20-12:40
Biography:
Abstract:
Sebnem Calik
Saglik Bilimleri University Izmir Bozyaka, Turkey
Title: Colonoscopy and Infectious Disease
Time : 12:00-12:20
Biography:
Sebnem Calik has completed her MD at Trakya University and Post-doctoral studies at Ege University, Medical Faculty of Infectious Diseases and Clinical Microbiology Clinic. She is a Specialist at Saglik Bilimleri University, Ä°zmir Bozyaka Education and Research Hospital, Infectious Diseases Department. She is interested in Febrile Neutropenia, Bloodstream Infection, Nosocomial Infection and Fungal Infection. She has published more than 20 papers in reputed journals and has been serving as an Editorial Board Member of repute.
Abstract:
Colonoscopy is the endoscopic examination of the large bowel and the distal part of the small bowel with a camera on a flexible tube passed through the anus. It can provide a visual diagnosis (e.g. ulceration, polyps) and grants the opportunity for biopsy or removal of suspected colorectal cancer lesions. Complications of colonoscopy are rare. These complications are perforation, bleeding, anaesthesia related bowel preparation and infection. The rate of infection was found as 1/1.8 million. The risk of infection development differs depending on gastrointestinal system region in which the endoscopic procedure is performed, and on type of procedure, and on patient’s underlying disease. The incidence of bacteremia after colonoscopy whether with or without biopsy and polypectomy varies between 0 and 25%. Bacteremia developing in immuno competent patients during or after colonoscopy is generally transient or asymptomatic. The incidence of transient bacteremia in flexible endoscopes varies between 0 and 1%. Colonoscopy related infections are of two forms: 1) Endogenous infection: The spread of patients own microbial flora in gastrointestinal system to other organs or prosthesis via the bloodstream during colonoscopy. Endoscopic procedures most often result in endogenous infections (i.e., infections resulting from the patient's own microbial flora), and E. coli, Klebsiella spp., Enterobacter spp., and Enterococci are the species most frequently isolated. 2) Exogenous infections: The spread of microorganisms from one patient to other patient by a contaminated endoscope (opportunistic pathogens such as bacteria, HBV, HCV, fungi, parasites etc.). The important risk factors of exogenous infections in colonoscopy are the number of microorganisms present inside the endoscope or biofilm production, invasive procedure which is resulting tissue damage, immuno compromised status of the patients (malignancy, solid organ transplantations, immunosuppressive treatment, human immunodeficiency virus, etc.) and presence of infectious focus during colonoscopy. Such infections are preventable with strict adherence to accepted reprocessing guidelines.
Cheng Zhang
The Ohio State University, USA
Title: Ulcerative Colitis (UC) - Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion and Parental Nutrition Than Crohn’s Disease (CD) - Associated CRC Patients - A Propensity Match Study
Time : 11:40-12:00
Biography:
Abstract:
Liana Kurmanseitova
Stavropol State Medical University, Russia
Title: Complications of Antegradny Access at the Decompression of Bilious Channels at Patients with Mechanical Jaundice and Ways of their Treatment
Time : 11:00-11:20
Biography:
Liana Kurmanseitova completed her PhD in Medicine at Moscow State University of Medicine and Dentistry. She is a Professional Surgeon in the field of Intervention Surgery and currently employed at the clinic of endoscopic and minimally invasive surgery under Stavropol State Medical University. She has a vast experience in the “Medical treatment of patients with obstruction jaundice”. She has participated in more than 15 international conferences and performed two on-line workshops for the wide audience.
Abstract:
Bulent Calik
University Izmir Tepecik Education and Research Hospital, Turkey
Title: Acute pancreatitis cases in Turkey: A review of the literature between 1980 and 2016
Time : 10:40-11:00
Biography:
Bulent Calik has completed his MD at Cukurova University, Turkey and Post-doctoral studies at Saglik Bilimleri University, Tepecik Education and Research Hospital in General Surgery department. He is the Chief Assistant at Saglik Bilimleri University Ä°zmir Tepecik Education and Research Hospital. He is interested in Oncological Surgery, Robotic Surgery, Laparoscopic Surgery and Colorectal Surgery. He has published more than 20 papers in reputed journals and has been serving as an Editorial Board Member of repute.
Abstract:
This study is a review of the literature related to acute pancreatitis in Turkey. In order to find the published reports on this subject, national database (Tübitak Ulakbim Turkish Medical Literature database, http://www.turkishmedline.com, and two international databases [Index Medicus and Science Citation Index (SCI)-expanded] were searched. Key words for national database were acute pancreatitis, akut pankreatit and the key words for index medicus and SCI-e were acute pancreatitis and Turkey. More than three published case reports were included. Data for 959 patients with acute pancreatitis were obtained from 13 reports. Of the patients, 381 (40%) were males and 578 (60%) females. Their ages ranged from 16 to 107 years. Etiological factors were biliary in 674 (70%), alcohol in 70 (7%), hyperlipidemia in 40 (4%), diuretic usage in 12 (1%) and trauma in 11 (1%). 152 of all patients (16%) etiology were non-specific. Mortality was seen in 128 cases (13%). 265 (28%) patients had necrotizing pancreatitis. Of these necrosis rate is less than 30% in 76 (29%), 30-50% in 70 (26%), 50% in 107 (40%) patients. 12 patients (5%) had extra-pancreatic necrosis. 49 patients (5%) had abscesses in abdomen, 35 patients (4%) had pancreatic fistula, 16 patients (2%) had pseudocyst, 12 patients (1%) had bleeding into the abdomen, 10 patients (1%) had bile fistula, 10 patients (1%) had enterocutaneous fistula and seven patients (1%) had pancreatic abscesses. 12 patients (1%) had endocrine pancreatic insufficiency, three patients (0.3%) had exocrine pancreatic insufficiency. 59 of all patients (6%) developed multiple organ failure. Relaparotomy was performed in 19 patients (7%) with necrotic pancreatitis. Despite continuing technological advances in diagnosis and treatment, acute pancreatitis remains a disease with high morbidity and mortality.
Errawan R Wiradisuria
Indonesian Society of Endo-Laparoscopic Surgeons (ISES), Indonesia
Title: Recent Advances in Cbd Stones Management, Laparoscopic Common Bile Duct Exploration (LCBDE)
Time : 10:20-10:40
Biography:
Since laparoscopic cholecystectomy was done for the first time by Philippe Mouret (France, 1987), the development of minimally invasive surgery in the hepatobiliary system has been progressing, followed by Berci, Phillips (USA, 1991) who has done laparoscopic common bile duct exploration (LCBDE) successfully later on. Abnormal intraoperative cholangiogram, unsuccessful attempts at endoscopic stone extraction for large/occluding stones, and intrahepatic stones are the indications for a LCBDE. While contraindications for the procedure, such as inability of the surgeons to perform the necessary maneuvers, absent of indication, instability of the patient, local condition in the porta hepatic made exploration hazardous, diameter of cystic duct less than 4 mm (transcystic procedure) or diameter common bile duct (CBD) less than 6 mm (transcholedochal). Three major options in management of cholelithiasis with CBD stone were open cholecystectomy with CBD exploration, endoscopic sphincterotomy and stone extraction followed by laparoscopic cholecystectomy (two stages) or laparoscopic cholecystectomy and laparoscopic CBD exploration done in one stage. Choice of the treatment was based on patient safety consideration, time efficiency, and cost effectiveness. Surgeons’ competency becomes an important role to determine a successful LCBDE. Availability and preparedness of instruments/equipment included Endoscopic Retrograde Cholangiopancreatography (ERCP) facilities are also the crucial supporting factors. LCBDE in Jakarta was done from August 2004 to July 2016 with 44 cases. Mean age of the patients were 52 years. Mean operation time was approximately 3.5 hours, with mean hospital stay about 5.5 days. Conversion of the operation was caused by impacted stones, massive adhesion (anatomical reason) or instrument failures. Several complication or morbidity after the surgery included retained stone, subphrenic abscess, T-tube insertion leakage, respiratory tract infection, urinary tract infection and superficial wound infection. Recently, the LCBDE become an important alternative choice in the treatment of CBD stone, especially in the failure of ERCP/endoscopic stone extraction. LCBDE as a minimally invasive procedure has the advantages with high success rate, low morbidity, and mortality rate and faster post-operative period recovery. However, we still need more training and learning curve.
Abstract:
Errawan R Wiradisuria is the President of Indonesian Society of Endo-Laparoscopic Surgeons and Chairman of Advance Laparoscopic Surgery courses (Asia-Pacific). He has published numerous papers in reputed journals and has been serving as an Editorial Board Member of repute.
Esam Elshimi
National Liver Institute, Menoufiya University, Egypt
Title: Current safety and feasibility of ERCP in management of early and late post liver transplant biliary complications
Time : 10:00-10:20